Star Health Reports 21% YoY Profit Growth to 518 Cr; COR Improves by 170 bps in H1FY26 under IFRS

* 24% growth in fresh retail premiums* Expense ratio improves to 29.7% from 31.1% (IFRS) ...

Health Check: CSL is not out of the woods yet, bearish analysts warn

CSL (ASX:CSL) analysts haven’t exactly given up on the stock following yesterday’s revenue and earnings downgrade.